![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 292, Issue 3, 1094-1103, March 2000
Ecole Nationale Vétérinaire de Toulouse, et Institut
National de la Recherche Agronomique; Unité Associée de
Physiopathologie et Toxicologie Expérimentales, Toulouse, France
The influence of a renal injury on the disposition of benazeprilat, the
active moiety of benazepril, and of enalaprilat, the active moiety of
enalapril, two angiotensin-converting enzyme (ACE) inhibitors (ACEI),
having different routes of elimination in dog was investigated during a
mild renal insufficiency obtained by a nephrectomy-electrocoagulation
method reducing glomerular filtration rate by ~50%. Plasma
concentrations of the active moieties were analyzed with a
physiologically based model taking into account the binding to ACE
(high affinity, low capacity). An influence of renal insufficiency on
enalapril disposition was shown with an increase in its plasma
concentration, which was correlated to the reduction of the glomerular
filtration rate. No such effect was evidenced for benazepril. With the
physiologically based model analysis, it was shown that renal
impairment led to an increase of the apparent benazeprilat clearance
(260%), whereas that of enalaprilat was reduced to 40 to 55%. Renal
insufficiency had no significant effect either on the apparent volume
of distribution of each drug or on the binding parameters [i.e.,
maximal binding capacity (Bmax) and affinity
(Kd)]. Enalaprilat and benazeprilat inhibitory action on ACE also was evaluated ex vivo. Similar patterns of inhibition were observed for both drugs. Renal injury had no significant influence on the overall effect of benazeprilat, whereas the inhibition effect of enalaprilat was significantly increased. It
was concluded that renal insufficiency may have effects on the ACEI
disposition but that the measurable active moiety plasma concentration
is not the most appropriate endpoint to describe and interpret the
consequence of a renal injury on ACEI.
This article has been cited by other articles:
![]() |
T. Comfere, J. Sprung, M. M. Kumar, M. Draper, D. P. Wilson, B. A. Williams, D. R. Danielson, L. Liedl, and D. O. Warner Angiotensin System Inhibitors in a General Surgical Population Anesth. Analg., March 1, 2005; 100(3): 636 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Toutain, H. P. Lefebvre, and J. N. King Benazeprilat Disposition and Effect in Dogs Revisited with a Pharmacokinetic/Pharmacodynamic Modeling Approach J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1087 - 1093. [Abstract] [Full Text] |
||||